Pharmacy News

Over-the-Counter Drugs

Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days

Articles(s): 1 - 6 of 6 Go To Page:

9/2/10 - The Law Office of Robbins Umeda LLP Announces Investigation of Allergan, Inc.

Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of the law by certain officers and directors at Allergan, Inc.. Robbins Umeda LLP's investigation concerns whether the Company's directors and officers damaged Allergan by encouraging doctors to prescribe Botox for uses the U.S. Food and D

9/1/10 - [CTU]-FDA panel recommends approval of new emergency contraceptive pill

FDA panel recommends approval of new emergency contraceptive pill. Ulipristal acetate pill already available in 22 European countries. American women might have another option in emergency contraception if the Food and Drug Administration follows the recommendation of its reproductive health panel in approving ulipristal acetate.

9/1/10 - Cipla Medpro Benefits From New Drugs

SA's fourth-largest pharmaceutical firm, Cipla Medpro, reported strong revenue and profit growth for the six months to June, as it benefited from the introduction of new drugs. This enabled the company to declare its maiden interim dividend of 5c a share. Revenue was up 29% to R714m from R555m in the same period last year.

8/31/10 - FDA looks to curb abuse of cough medicine

WASHINGTON Federal health regulators are weighing restrictions on Robitussin, NyQuil and other cough suppressants to curb cases of abuse that send thousands of people to the hospital each year. The Food and Drug Administration on Tuesday posted its review of dextromethorphan, an ingredient found in more than 100 over-the-counter medications that

8/31/10 - MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone Sublingual Film for Treatment of Opioid Dependence

WARREN, N.J., Aug. 31 MonoSol Rx, the developers of PharmFilm technology and a drug delivery company specializing in film pharmaceutical products, today announced that its partner, Reckitt Benckiser Pharmaceuticals Inc., a wholly-owned subsidiary of Reckitt Benckiser Group plc, has received approval from the U.S. Food and Drug Administration to m

8/31/10 - RECKITT BENCKISER GROUP PLC - Receives FDA Approval for Suboxone Sublingual Film

Reckitt Benckiser Group plc Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Approval for Suboxone (Buprenorphine and Naloxone) Sublingual Film C-III Richmond, VA (31st August 2010) - Reckitt Benckiser Pharmaceuticals Inc. today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for its New Drug Applicatio

Articles(s): 1 - 6 of 6 Go To Page: